Stand-Alone Posts

The COVID-19 pandemic has raised salient questions about global intellectual property rights rules and their implementation at regional, sub-regional and national levels. These questions revolve around the tensions between private rights and the public interest. For example, how can governments employ flexibilities and other measures to facilitate access to pharmaceutical products including drugs, vaccines, test kits, personal protective equipment and related technologies? Or how can governments navigate the intersections of copyright and the right to education to promote access to educational materials for teaching and learning? Broader conceptual, practical, and institutional issues, foregrounded on fostering development-oriented intellectual property rights systems in the Global South, will be analysed from different perspectives.

Traditional medicines have an equally important role as vaccines, therapeutics and medical devices protected through classical IPRs such as patents. For this reason, it is important to include traditional medicines within the scope of IPR protection, including within the WTO’s TRIPS Agreement. Doing so would go beyond the classical debate of protecting medicines, vaccines and therapeutics mainly through patents as currently understood within the TRIPS Agreement.

As all the services carry the risk of financial crime such as money laundering and terrorism financing and risks to users (investors such as those investing through crowdfunding) regulation is key. Rather than regulate them out of existence, however, African economies should embrace a regulatory friendly approach to their operation which would be vital to: provide SMEs and individuals access to finance; kick start economies; create jobs and set Africa on the trajectory of growth again post the Covid-19 crises.

governments need to ensure that the interventionary measures they seek to implement must be tempered with and evaluated against the special needs and dynamics of their countries. The fragility of our economies, the growing debt levels, the development challenges they pose, and the social and economic vulnerability of a significant segment of our populations ought to be important considerations in developing response and containment measures against Covid-19.

On 22 April, the President of Madagascar Andry Rajoelina, launched what he called a cure for coronavirus, Covid Organics (CVO). The announcement drew interest from a few African countries and to date countries like Tanzania, Guinea Bissau, The Gambia and Senegal have already received shipment of CVO. While some have been sceptical about the remedy, others have praised it as an example of traditional medicine, reigniting a discussion around traditional medicine and intellectual property rights.

The question of a regulatory framework for this type of CSR at the African Union level is paramount. Such regulatory frameworks could be meta-regulatory in nature and thus embrace a mix of soft law and hard law rules with incentives. This need for policy and regulation is recognised in the African Union Agenda 2063 framework document both in order to effectively finance development objectives and to enable full exploitation of the partnership capabilities in the interest of Africa. The African Union has also pursued this set goal for agribusiness as a result of the Malabo declaration on accelerated agricultural growth commitments

In addition to BITs and IP laws, the Nigerian government can rely on the international law principle of necessity to justify taking measures such as compulsory licencing, yet the successful use of this principle depends on satisfying various conditions. Meanwhile, applicability of the customary doctrine of police powers to the claims arising under BITs has been accepted. This means that ISDS tribunals should thus attach normative propriety to state regulation in an epidemic.

Halting the rapid transmission of COVID-19 and reversing the trend of consequential global distress is a global concern and goal. As the WHO has rightly pointed out, this goal is only achievable when everyone, everywhere can access the health technologies they need for COVID-19 detection, prevention, treatment and response. This highlights the importance of international cooperation and solidarity for restoring global health security, now and for the future.

The Symposium will combine essays that are invited and that are selected from the submissions responding to this Call. We welcome essays responding and reflecting on the issues and perspectives raised by the report on `Teaching and Researching International Law in Asia’ recently released by the Centre for International Law.

There are many great things to say about the volume including the discussion about Africanization of international investment law and finding Africa's voice in it. Much of what one would have expected to see about Africa and ICSID is in there.